Press "Enter" to skip to content

New patent expiration for Astrazeneca drug ZOMIG

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Astrazeneca drug ZOMIG

Annual Drug Patent Expirations for ZOMIG
Annual Drug Patent Expirations for ZOMIG

Zomig is a drug marketed by Astrazeneca and IPR and is included in three NDAs. It is available from one supplier. There are two patents protecting this drug and two Paragraph IV challenges.

ZOMIG drug price trends.

Drug patent litigation for ZOMIG.

The generic ingredient in ZOMIG is zolmitriptan. One supplier is listed for this compound. Additional details are available on the zolmitriptan profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Astrazeneca drug ZOMIG
    Online Certificate Course

    Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

    • When will key drug patents expire?
    • How can I find, evaluate, and plan for generic market entry opportunities?
    • How can I find proprietary out-of-court settlements and deal terms?
    DrugPatentWatch - Make Better Decisions